Please enter the email address you used to register, then we will send you a link to choose a new password
https://www.sec.gov/ix?doc=/Archives/edgar/data/1850838/000119312525019359/d927659d8k.htm On February 3, 2025, the Company, wit...
On January 13, 2025, Omega Therapeutics, Inc. (the "Company") received a notice of default (the "Notice of Default&...
Under the terms of the Proposal, Mirai would acquire all of the Company's rights and obligations under the Collaboration Ag...
Piper Sandler analyst Edward Tenthoff maintains Omega Therapeutics (NASDAQ:OMGA) with a Overweight and lowers the price targ...
Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of ...
Established clinical proof-of-mechanism and validation of epigenomic controllers as potential new class of medicines from compl...